Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on September 4, 2025
Marimaca Copper Announces A$80,000,000 Placement
GlobeNewswire
·
September 4, 2025
Not for release to U.S. wire services or for distribution in the United States VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (TSX: MARI) (ASX: MC2) (“Marimaca” or the “Company”) is pleased to announce that it is …
ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 4, 2025
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on …
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 4, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Microchip Technology to Present at the Goldman Sachs Communacopia + Technology Conference
GlobeNewswire
·
September 4, 2025
CHANDLER, Arizona, Sept. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Goldman Sach …
NBME celebrates 110th anniversary of advancing assessment in medical education
GlobeNewswire
·
September 4, 2025
PHILADELPHIA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- This year, NBME celebrates 110 years of creating high-quality assessments for medical learners. As a not-for-profit organization, NBME aims to advance assessment of health care professionals to achieve …
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
GlobeNewswire
·
September 4, 2025
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual …
TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization
GlobeNewswire
·
September 4, 2025
Paris, France, Cambridge, USA, September 4 2025 - TISSIUM, a MedTech company pioneering biomorphic programmable polymers for tissue reconstruction, today announced further progress in its clinical pipeline of atraumatic solutions following the recent U.S. …
ServiceTitan Announces Strategic Partnership With Roto-Rooter
GlobeNewswire
·
September 4, 2025
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (Nasdaq: TTAN), the software platform that powers the trades, today announced a strategic partnership with Roto-Rooter, the largest provider of plumbing, drain cleaning, and water cleanup …
ServiceTitan Announces Fiscal Second Quarter Financial Results
GlobeNewswire
·
September 4, 2025
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced financial results for the fiscal second quarter ended July 31, 2025. “I am grateful for the way our team empowered …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 4, 2025
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
GlobeNewswire
·
September 4, 2025
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025. The …
Service Coordination, Inc. President & CEO John Dumas Named One of Maryland’s 2025 Most Admired CEOs
GlobeNewswire
·
September 4, 2025
Frederick, MD, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Daily Record has named John Dumas, President …
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
GlobeNewswire
·
September 4, 2025
Another addition to Amneal’s growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the …
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
September 4, 2025
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Praxis Precision Medicines to Participate in September Investor Conferences
GlobeNewswire
·
September 4, 2025
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders …
Indaptus Therapeutics Provides Clinical Update
GlobeNewswire
·
September 4, 2025
Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases Decoy20 combination with PD-1 inhibitor, tislelizumab, demonstrates safety profiles consistent with each agent NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- …
Inventiva to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, United States), September 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment …
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, Etats-Unis), le 4 septembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de …
Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas
GlobeNewswire
·
September 4, 2025
The risk adjusted Net Present Value (rNPV) for TVGN 930 is estimated to exceed ~$250 million in the US alone. Covering five rare disease eligible indications, the accessible market in the US could be as high as 40,000 patients. Focused on improved …
Auto Air Pump: How Auto Air Pump Redefines Tire Pressure Pumps with Auto Tire Inflator, Mobile Air Pump & Portable Inflator Tech
GlobeNewswire
·
September 4, 2025
New York City, NY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Introduction – Auto Air Pump: Ending Flat-Tire Stress In 2025, mobility is more than just getting from one point to another—it’s about ensuring every journey is safe, efficient, and stress-free. Few …